Bubs share price surges 10% on new Woolworths deal

The Bubs Australia Ltd (ASX: BUB) share price is rocketing this morning after announcing a new deal with Woolworths Group Ltd (ASX: WOW).

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Bubs Australia Ltd (ASX: BUB) share price will be on watch this morning after the infant formula company announced it has entered a new supply agreement with Woolworths Group Ltd (ASX: WOW).

Bubs shares rocketed 7.14% when the market opened this morning and are now trading 10% higher at $0.77 at the time of writing.

a woman

Details of the new deal with Woolworths

Bubs first entered into a supply agreement with Woolworths in February 2018, which involved stocking Bubs' Goat Milk Infant Formula products in 120 stores.

This new updated agreement will see Bubs now offer its entire range of eight infant formula products across a targeted selection of Woolworths' 700 national store network.

Bubs commented that the super-premium segment, which includes goat milk and organic formula products, is the fastest-growing sector of the infant nutrition category and now represents more than half of the total infant formula market in Australia.

Under the new agreement with Woolworths, all three stages of Bubs Goat Milk Infant Formula store representation will increase more than threefold to 400 stores.

The new Bubs Organic 365 days Grass Fed Infant Formula range was recently launched into over 300 stores in the Australian pharmacy channel in Q2 FY20. All three stages will now be ranged across 700 Woolworths supermarkets.

The agreement also secures ranging for Bubs' new Junior Nutrition range to be sold in 100 premium Woolworths stores. The Australian launch will coincide with the launch of a registered China label equivalent Goat Junior Nutrition product with iron-binding protein lactoferrin, to be ranged in mother and baby stores in China. The Junior Nutrition category in China is worth an estimated $1 billion and has experienced double-digit growth since 2017.

Bubs anticipates doubling of its domestic shelf space exposure

Bubs commented that it anticipates the new agreement will have the effect of more than doubling its shelf space exposure and retail points of distribution across the Australian grocery retail sector. Further, the company is confident it will have a significant uplift in its domestic volume and expects the deal to materially add to its domestic revenues.

In-store implementation of Bubs Organic Grass Fed Infant Formula will commence in March 2020 with full distribution completed by the end of May. All other new products and additional store ranging for existing products will also be rolled out into stores by the end of May.

Bubs noted that around $3.3 million infant formula base powder and finished goods inventory was produced in Q2 FY20. This was in preparation for the Woolworths expansion of Bubs Goat formula products, the national roll-out of Bubs Organic formula products, and to fulfil opening orders for the launch of both Goat and Organic Junior Nutrition products into multiple retail channels.

Motley Fool contributor Phil Harpur has no position in any of the stocks mentioned. The Motley Fool Australia has recommended BUBS AUST FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A disappointed man slumps in his chair and holds his head while playing an online game
Share Market News

These 4 ASX 200 shares have slumped to fresh 52-week lows: Buy, sell or hold?

Should investors buy in the dip or sit on the sidelines?

Read more »

smiling health care workers in a medical setting
Share Market News

3 ASX healthcare shares to buy amid sector rout: experts

Healthcare shares have tumbled 36% over the past year amid multiple headwinds for the sector.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Beach Energy, Domino's, Origin Energy, and Pantoro Gold shares are dropping today

Why are these shares under pressure? Let's find out.

Read more »

A woman wearing a hard hat holds two sparking wires together as energy surges between them.
Share Market News

Origin Energy shares slump 10% this week: Buy, sell or hold?

The ASX energy company has hit some headwinds. How much longer can they continue?

Read more »

Person pressing the buy button on a smartphone.
Broker Notes

3 reasons to buy Pro Medicus shares today

A leading analyst believes Pro Medicus shares are now trading at a significant discount.

Read more »

Two men look excited on the trading floor as they hold telephones to their ears and one points upwards.
Broker Notes

Buy, hold, sell: Sigma Healthcare, Macquarie, Santos shares

Brokers reveal their latest ratings and reviews on 3 ASX 200 stocks.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Share Gainers

Guess which ASX rare earths stock just leapt 68% on big acquisition news

Investors are piling into the ASX rare earths miner today after it emerged from a lengthy trading halt.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Share Gainers

Why Elsight, IperionX, Predictive Discovery, and Reliance shares are pushing higher today

Let's see why investors are bidding these shares higher today.

Read more »